These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34933669)

  • 1. Appearance of claudin-5
    Krajewski D; Paul D; Ge S; Jellison E; Pachter JS
    J Neuroinflammation; 2021 Dec; 18(1):296. PubMed ID: 34933669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of claudin-5
    Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
    J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
    Paul D; Cowan AE; Ge S; Pachter JS
    Microvasc Res; 2013 Mar; 86():1-10. PubMed ID: 23261753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
    Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B
    Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
    Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
    PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
    Bénardais K; Pul R; Singh V; Skripuletz T; Lee DH; Linker RA; Gudi V; Stangel M
    Neurosci Lett; 2013 Oct; 555():165-70. PubMed ID: 24076006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-12 is not required for blood-brain barrier tight junction function.
    Castro Dias M; Coisne C; Baden P; Enzmann G; Garrett L; Becker L; Hölter SM; ; Hrabě de Angelis M; Deutsch U; Engelhardt B
    Fluids Barriers CNS; 2019 Sep; 16(1):30. PubMed ID: 31511021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
    Pfeiffer F; Schäfer J; Lyck R; Makrides V; Brunner S; Schaeren-Wiemers N; Deutsch U; Engelhardt B
    Acta Neuropathol; 2011 Nov; 122(5):601-14. PubMed ID: 21983942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
    Tietz SM; Engelhardt B
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.
    Argaw AT; Gurfein BT; Zhang Y; Zameer A; John GR
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1977-82. PubMed ID: 19174516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
    Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
    PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
    Lee E; Chanamara S; Pleasure D; Soulika AM
    J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.
    Sagar D; Lamontagne A; Foss CA; Khan ZK; Pomper MG; Jain P
    J Neuroinflammation; 2012 Oct; 9():245. PubMed ID: 23102113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes.
    Hannocks MJ; Zhang X; Gerwien H; Chashchina A; Burmeister M; Korpos E; Song J; Sorokin L
    Matrix Biol; 2019 Jan; 75-76():102-113. PubMed ID: 29158162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
    Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
    Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation.
    Samus M; Seelige R; Schäfer K; Sorokin L; Vestweber D
    J Leukoc Biol; 2018 Oct; 104(4):787-797. PubMed ID: 29791026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.